WCN26-7609 Analysis and therapy of renal tubular dysgenesis-causing AGT deletion/insertion mutation conditional knock-out mice

Shih-Hua Lin; Min-hua Tseng

doi:10.1016/j.ekir.2026.104905

March 25, 2026Kidney International ReportsOpen Access

WCN26-7609 Analysis and therapy of renal tubular dysgenesis-causing AGT deletion/insertion mutation conditional knock-out mice

View Full Paper

Ask AI

Bookmark

Share

Key Points

To evaluate the effectiveness of dexamethasone as a rescue therapy for renal tubular dysgenesis caused by AGT mutations in mice.
Used conditional knockout mice to specifically investigate AGT's role.
Administered dexamethasone to treat the condition.
Conducted assessments of treatment efficacy in the model.
Dexamethasone showed potential in mitigating the effects of AGT mutations.
Conditional knockout mice allowed for precise evaluation of AGT's impact on renal function.

Implication

Assesses dexamethasone therapy for renal tubular dysgenesis in knockout mice, suggesting potential treatment strategies.

Abstract

This study assessed dexamethasone as rescue therapy for fatal autosomal recessive renal tubular dysgenesis (ARRTD) due to AGT mutation, with conditional knockout mice enabling targeted investigation of AGT’s role and precise evaluation of treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lin et al. (2026) studied this question.

synapsesocial.com/papers/69c6201515a0a509bde18815 https://doi.org/10.1016/j.ekir.2026.104905

View Full Paper

Ask AI

Bookmark

Share

WCN26-7609 Analysis and therapy of renal tubular dysgenesis-causing AGT deletion/insertion mutation conditional knock-out mice

Key Points

Implication

Abstract

Discussion

Cite This Study

WCN26-7609 Analysis and therapy of renal tubular dysgenesis-causing AGT deletion/insertion mutation conditional knock-out mice

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading